In mammary cancers, FOXP3 is found to regulate HER-2 and SKP2 by repressing their expression, and importantly these genes are linked to a poor prognosis in the cases with breast carcinoma (Martin et al., 2010). Here, ERBB2 is linked to breast cancer.